Investment Strategies - Warren Buffett's legacy emphasizes a buy-and-hold investment strategy, focusing on exceptional stocks and minimizing impulsive trading [1] Enterprise Products Partners (EPD) - EPD has a current stock price of $32.01 with a 12-month price forecast of $36.67, indicating a 14.54% upside potential [2] - Despite missing earnings expectations, EPD reported nearly 5% year-over-year revenue growth, showcasing resilience [3] - EPD offers a high dividend yield of 6.70% with a payout ratio of 80.15%, supported by a strong balance sheet and a history of increasing distributions [4] Intuitive Machines (LUNR) - Intuitive Machines has a current stock price of $10.45 and a 12-month price forecast of $16.06, representing a 53.64% upside potential [5] - The company is positioned to become a leading provider of lunar services as NASA plans future missions [6] - Analysts recommend a long-term view, with six out of nine analysts rating LUNR as a Buy, indicating an upside potential of over 47% [7][8] Alaska Air Group (ALK) - Alaska Air Group's current stock price is $47.40, with a 12-month price forecast of $66.83, suggesting a 41.00% upside potential [9] - The company is expanding through its Alaska Accelerate initiative and aims to generate $1 billion in incremental profit by 2027 [10] - Despite a 25% decline in shares over the past year, 11 out of 12 analysts view ALK as a Buy, indicating strong future potential [11] Service Corporation International (SCI) - Service Corporation International has a current stock price of $78.43 and a 12-month price forecast of $89.25, indicating a 13.80% upside potential [13] - The death services market is expected to grow significantly as the Baby Boomer generation ages, creating increased demand for services [14] - SCI is adapting to market changes with an insurance-funded pre-need sales model and has the infrastructure to meet rising demand [15]

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Kiniksa Pharmaceuti cals (NASDAQ: KNSA ) is outperforming this year. The stock has advanc ...

SINGAPORE, June 16, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today provided a business update outlining its recent accomplishments as the Company prepares for its inaugural earnings call following its successful Nasdaq listing in May 2025. Operational Highlights New order win in Angola and renewed contract in Thailand; S ...

Strategic federal initiative includes appointment of Jason Chasse, a US Federal and Military sales veteran with over 30 years of experience, as Director of Federal Sales.FREMONT, Calif, June 16, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that it is accelerating its federal and military market expansion initiatives. As part of this stra ...

Neve Yarak, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable and innovative solutions for solar energy and agri-tech markets, today announced plans to increase its investment in the 111 MWp solar photovoltaic project in Melz, Germany, to explore the integration of a 40–60 MWp battery energy storage system (BESS). This investment is part of N2OFF’s intention to advance its renewable energy business. The Melz ...

Well-positioned to pursue strategic transformation, supported by strong leadership bench and extended financial runwayGRAPEVINE, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (NYSE: DTC; OTC: DTCB) (“Solo Brands” or “the Company”), a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, today announced that Mr. John P. Larson was appointed as permanent President and Chief Executive Officer, effective immediately. Mr. L ...

Operational Highlights May Occupancy in May reached 77%, an increase of 22 percentage compared to May 2024.The number of Cabin Nights rose by 50% year-over-year.Average Cabin Revenue (ACR) increased by more than 10% compared to May 2024.Total ticket revenue grew by over 67% year-over-year.Note: May 2024 results were impacted by cancellations and rebookings due to technical issues with Havila Pollux, which affected two roundtrips. Booking Position 2025 As of today, 63% of 2025 capacity is booked, representi ...

While NVIDIA NASDAQ: NVDA remains the undisputed leader in AI GPU and infrastructure, its first-mover advantage doesn’t mean it's better. Advanced Micro Devices NASDAQ: AMD GPUs offer advantages to NVIDIA in many use cases due to their dollar-cost efficiency, user-friendliness, and superior compatibility with a wide range of 3rd-party products. The advantages run into performance. Advanced Micro Devices MI 355X has superior memory capacity and bandwidth to NVIDIA's Blackwell, making it an exceptional choice ...

WILMINGTON, Del., June 16, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), a multi-site clinical care delivery organization and wholly-owned subsidiary of NRx, today announced a strategic investor relations partnership with astr partners, a boutique investor relations and capital advisory firm focused on the life sciences sector. HOPE Therape ...

At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which took place in Glasgow, Scotland, from 13 to 16 June 2025, the Danish pharmaceutical company ALK presented extensive data on anaphylaxis and paediatric allergy. During the EAACI 2025 scientific programme, ALK sponsored two major symposia and participated at several oral sessions, presenting data on the latest innovation in anaphylaxis, children with respiratory allergy, and recent advances in peanut food allergy. ...